Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony sti...
Leadership
Dennis M. Lanfear
Chairman, President & CEO
Bryan J. McMichael
Chief Financial Officer
Carrie Graham
Vice President of Investor Relations & Advocacy
Andy Rittenberg
Chief Legal Officer
Rebecca Sunshine
Chief Human Resources Officer
Michael Chen
Senior Vice President of Commercial Analytics & Trade
Theresa M. Lavallee Ph.D.
Chief Development Officer & Chairman of Scientific Advisory Board
